Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
A Single Arm Phase 2 Study of Y-90 SIRT in Combination With Durvalumab (MEDI 4736) and Gemcitabine/Cisplatin in Locally Advanced, Unresectable or Metastatic Intrahepatic Cholangiocarcinoma
This trial is designed to study a combination of interventions (chemotherapy, immunotherapy, and radiation) as a potential new treatment for bile duct cancer t…
Bile Duct CancerCholangiocarcinomaCholangiocarcinoma Non-resectable+2 more
Beth Israel Deaconess Medical CenterNCT05655949
Observational
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
Over the past three decades, the treatment of both primary and secondary liver malignancies has been improved by the development and optimization of multiple m…
Liver Malignant TumorsCholangiocarcinoma MetastaticPancreatic Cancer+1 more
M.D. Anderson Cancer CenterNCT05053555